Our analysis revealed an overlapping pattern associated with acquired resistance to ICB in this different tumor type, supporting the notion that EMT-associated repression of Irf6 is a generalized mechanism of acquired resistance to immunotherapy. Here, IRF6 is linked to neoplasm.